CADL News

The 2021 US IPO market continues to break records. 20 IPOs went public this past week, the most in a single week since the year 2000. New filers have slowed ahead of the August lull, with just one IPO submitting an initial filing. Three issuers postponed, citing either volatility or market conditions: vehicle battery maker Clarios International (BTRY), specialty...read more

Candel Therapeutics, a Phase 3 biotech developing oncolytic viral immunotherapies for cancer, raised $72 million by offering 9 million shares at $8, as expected. The company originally planned to offer 6.1 million shares at a range of $13 to $15, before revising the terms on Monday. Candel's most advanced candidate, CAN-2409, is an off-the-shelf adenovirus...read more

Candel Therapeutics, a Phase 3 biotech developing oncolytic viral immunotherapies for cancer, lowered the proposed deal size for its upcoming IPO on Monday. The Needham, MA-based company now plans to raise $72 million by offering 9 million shares at $8. The company had previously filed to offer 6.1 million shares at a range of $13 to $15. At the revised deal size, Candel...read more

Updated Monday, 7/26. After another week of record activity, the IPO market is expected to remain hot with 25 IPOs scheduled for the week ahead. If all scheduled IPOs begin trading as expected, it would be the busiest week for the US IPO market in more than two decades. Long-awaited retail brokerage Robinhood Markets (HOOD) plans to raise $2.2...read more